11monon MSN
AbbVie targets $24B in 2025 sales from Skyrizi and Rinvoq, outlines robust mid-single-digit growth
CEO Rob Michael highlighted AbbVie's strong Q4 2024 performance, which exceeded initial guidance with $56.3 billion in total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback